Intuitive Surgical's stock is prone to drawdowns, and January could be an opening for long-term growth investors.

Intuitive Surgical, Inc. (ISRG) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Intuitive Surgical ISRG delivered robust 2025 results, beating estimates on both counts. Total revenues rose 20.5% year over ...

If you are wondering whether Intuitive Surgical at around US$525 a share still makes sense for your portfolio, the key ...

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for investors.

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure growth in 2025.

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force Feedback instruments.

Intuitive Surgical looks like a long-term buy: strong Da Vinci 5 adoption, expanding FDA use cases, and multiyear-low valuation. Click here to read more.

Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.

Patient investors who ride out the storm could be rewarded down the road.

Why Intuitive Surgical stock is on investors’ radar today Intuitive Surgical (ISRG) is drawing attention after a period of ...